Topic
pharmaceutical-revenue
1 stories related to this topic, newest first.
insidermonkey.comfinance72 days ago
ImmunityBio Reports Record Q1 Revenue Tripling Year-Over-Year Driven by Anktiva
Zoetis reported lower-than-expected first-quarter 2026 results driven by U.S. headwinds and lowered its financial guidance. Separately, ImmunityBio shares dropped 11.46 percent despite record revenue growth from its cancer drug Anktiva.